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Abstract: Plants and their constituents have been used to treat diverse ailments since time immemo-
rial. Many plants are used in diverse external and internal formulations (infusions, alcoholic extracts,
essential oils (EOs), etc.) in the treatment of inflammation-associated diseases, such as those affecting
the respiratory tract or causing gastrointestinal or joint problems, among others. To support the tradi-
tional uses of plant extracts, EOs have been assessed for their alleged anti-inflammatory properties.
However, the effect of EOs on the release of cytokines and chemokines has been much less reported.
Considering their traditional use and commercial relevance in Portugal and Angola, this study
evaluated the effect of EOs on the in vitro inhibition of the cytokine tumor necrosis factor-α (TNF-α)
and the chemokine (C-C motif) ligand 2 (CCL2) by lipopolysaccharide (LPS)-stimulated human
acute monocytic leukemia cells (THP-1 cells). Twenty EOs extracted from eighteen species from
seven families, namely from Amaranthaceae (Dysphania ambrosioides), Apiaceae (Foeniculum vulgare),
Asteraceae (Brachylaena huillensis, Solidago virgaurea), Euphorbiaceae (Spirostachys africana), Lamiaceae
(Lavandula luisieri, Mentha cervina, Origanum majorana, Satureja montana, Thymbra capitata, Thymus
mastichina, Thymus vulgaris, Thymus zygis subsp. zygis), Myrtaceae (Eucalyptus globulus subsp. maidenii,
Eucalyptus radiata, Eucalyptus viminalis) and Pinaceae (Pinus pinaster) were assayed for the release of
CCL2 and TNF-α by LPS-stimulated THP-1 cells. B. huillensis, S. africana, S. montana, Th. mastichina
and Th. vulgaris EOs showed toxicity to THP-1 cells, at the lowest concentration tested (10 µg/mL),
using the tetrazolium dye assay. The most active EOs in reducing TNF-α release by LPS-stimulated
THP-1 cells were those of T. capitata (51% inhibition at 20 µg/mL) and L. luisieri (15–23% inhibition at
30 µg/mL and 78–83% inhibition at 90 µg/mL). L. luisieri EO induced a concentration-dependent
inhibition of CCL2 release by LPS-stimulated THP-1 cells (23%, 54% and 82% inhibition at 10, 30 and
90 µg/mL, respectively). These EOs are potentially useful in the management of inflammatory
diseases mediated by CCL2 and TNF-α, such as atherosclerosis and arthritis.
Keywords: essential oils; cytokine; chemokine; inflammation
1. Introduction
Since ancient times, man has used the plant kingdom as a source for clothing, con-
struction, fuel, food, spices and medicines, as well as for poisons. Nowadays, around
half the pharmaceutical drugs used in developed countries, such as aspirin, are of plant
origin [1]. Traditional medicine is still the main source of health care for 80% of the people
in developing countries, where medicinal plants are commonly used for the treatment of
several ailments, notably inflammatory diseases.
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Acute inflammation is a short-term reaction which is essential for survival after an
infection or a physical injury. On the other hand, chronic inflammation, promoted by social,
environmental and lifestyle factors (diet, smoking, alcoholism, inactivity), may trigger
diverse long-term illnesses such as cardiovascular disease, cancer, diabetes mellitus, chronic
kidney disease, nonalcoholic fatty liver disease and autoimmune and neurodegenerative
disorders [2]. These diseases and lifestyles are associated with atherosclerosis, the early
detection of which is based on peripheral artery and carotid artery thickness. In a recent
study of the epidemiological burden caused by carotid atherosclerosis, Song et al. [3]
estimated that, in 2020, the prevalence of increased carotid intima-media thickness in
people aged 30 to 79 years was about 28%, equivalent to approximately 1070 million
cases worldwide.
In Portugal, recent studies showed that as many as 740,000 adults are affected by
atherosclerosis [4]. Data on other inflammatory diseases in Portugal, such as rheumatic
diseases [5], showed that women (64%) are more affected by rheumatic diseases, including
rheumatoid arthritis, than men (47%). These diseases are underdiagnosed in Portugal and
are responsible for disability and absenteeism at work, with the consequent individual,
social and economic costs [5]. Much less is known about inflammatory diseases in other
Portuguese-speaking countries. There are no studies on the prevalence of rheumatic
diseases in Angola [6], although the occurrence of rheumatic fever, rheumatoid arthritis or
systemic lupus erythematosus is known [7].
Acute inflammation can be treated by using oral nonsteroidal anti-inflammatory
drugs (NSAIDs), despite being associated with adverse gastrointestinal and cardiovascular
effects [8,9]. It would be desirable to identify natural plant products with anti-inflammatory
properties but with fewer adverse effects. Despite the traditional application of plants,
their effects have not always been proven by scientific evidence. On the other hand,
scientific research sometimes provides evidence of biological activities for which the plants
in question had never been traditionally used.
Plant extracts, such as essential oils (EOs), have been used in traditional medicine as
anti-inflammatories, digestives, diuretics, expectorants and sedatives, along with other
applications (Table 1). Nowadays, in addition to their use in aromatherapy, essential oils
find application in cosmetics, cleaning products, fragrances, foods and beverages. Essential
oils have been reported to show several biological properties, including antimicrobial,
antioxidant, anti-inflammatory and anticancer properties, among others [10–12]. Partic-
ularly relevant is EOs’ anti-inflammatory activity, either by inhibiting several enzymes,
such as oxygenases, nitric oxide synthases and peroxidases, or by inducing the release of
pro-inflammatory cytokines, like interleukins and tumor necrosis factor-α (TNF-α) [10].
Table 1. Some of the traditional applications of the species studied in the present work.
Family/Plant Species Common Names(pt/en) Medicinal Use Other Uses Reference
Amaranthaceae
Dysphania ambrosioides (L.) Mosyakin
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Table 1. Cont.
Family/Plant Species Common Names(pt/en) Medicinal Use Other Uses Reference
Asteraceae/Compositae
Brachylaena huillensis O. Hoffm.
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Table 1. Cont.
Family/Plant Species Common Names(pt/en) Medicinal Use Other Uses Reference






























































pt/en: Official two-letter codes of Portuguese and English languages, respectively. * African name adopted in Portuguese. ** African name
given to the wood and adopted in Portuguese and English.
Chemokines constitute a family of chemoattractant cytokines. These are small heparin-
binding proteins involved in atherosclerosis by promoting directed migration of inflam-
matory cells. Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemoat-
tractant protein-1 (MCP-1), has been detected in atherosclerotic lesions [34]. CCL2 is
also a potent mediator of chronic inflammation, triggering, for instance, inflammation in
rheumatoid arthritis [35]. In addition, inflammatory response is characterized by increased
production of tumor necrosis factor-α (TNF-α) [35]. TNF-α, interleukin (IL)-1 and IL-6, se-
creted by macrophages, lymphocytes, natural killer cells and vascular smooth muscle cells,
are considered pro-atherogenic cytokines [36]. Despite the reported anti-inflammatory
potential of several EOs (Table 2), their effect on the release of CCL2 is much less reported
than the release of TNF-α.
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Table 2. Previously reported anti-inflammatory activity of the essential oils (EOs) from the species under study.
Family/Species EO/EO Components’ Anti-Inflammatory Activity Reference
Apiaceae
Foeniculum vulgare EO inhibition of 5-lipoxygenase (IC50 = 0.04 mg/mL). Fenchone inhibition of5-lipoxygenase (IC50 = 0.02 mg/mL).
[37]
EO (200 and 400 mg/kg) decreased the activity of mieloperoxidase (MPO) and the
expression of TNF-α in the colon tissue previously submitted to acetic acid solution (acute
colitis), and inhibited acetic acid-induced expression of p-NF-kB p65 protein.
[38]
Lamiaceae
Lavandula luisieri EO (50–200 mg/kg) inhibition of paw edema (31–83%) induced by carrageenanadministered in male Wistar rats. [39]
EO (25 µg/mL) nitric oxide (NO) inhibition (75%) in IL-1β induced primary chondrocyte. [40]
EO reduction of iNOS in human chondrocytes and intestinal cell line C2BBe1 (54.9 and
81.0%, respectively) and phosphorylated IkB-α (87.4% and 62.3%, respectively). [41]
Origanum majorana
EO (10 µg/mL) diminished the TNF-α, IL-1β, IL-6, IL-10 and COX-2 secretion and NFκB
gene expression after activation of THP-1 cells by lipopolysaccharide or human ox – LDL.
The activity was attributed to cis-sabinene hydrate and terpinen-4-ol.
[42]
Thymbra capitata EO inhibition of 5-lipoxygenase (IC50 = 0.1 mg/mL). [43]
EO inhibition of 5-lipoxygenase (IC50 = 0.2 mg/mL). [44]
Thymus mastichina EO inhibition of 5-lipoxygenase (IC50 = 0.7 mg/mL). [43]
Thymus vulgaris EO inhibition of 5-lipoxygenase (IC50 = 0.19 µg/mL). [37]
EO (0.5 µg/mL) inhibition (80%) of 5-lipoxygenase. [45]
EO inhibition of 5-lipoxygenase (IC50 = 0.005 µg/mL). EO reduced the TNF-α, IL-1β, IL-8
secretion levels of THP-1 cells. [46]
EO (400 mg/kg, after 6 h) reduced (50.4–58.4%) carrageenan-induced paw edema in mice. [47]
Carvacrol (10 mg/ear) reduced ear edema. Carvacrol (10 mg/ear) inhibited the activity of
myeloperoxidase (MPO) (43.8%). Carvacrol (0.3–90 µg/mL) reduced (20.07–52.23%)
neutrophil migration in response to fMLP stimulation. EO (750 mg/kg) and carvacrol
(100–400 mg/kg) exerted inhibited leukocyte migration to the injury site. Carvacrol
(0.3-90µg/mL) reduced LTB4 stimulation (19.8–61.1%).
[48]
EO and carvacrol suppressed lipopolysaccharide-induced COX-2 mRNA and protein
expression in human macrophage-like U937 cells. [49]
EO (moderate concentration) decreased the mRNA levels of IL-1β, IL-6,
granulocyte-macrophage colony stimulating factor (GM-CSF) and TNF-α, and lowered the
amount of IL-1β and IL-6 proteins in animal models of colitis.
[50]
EO reduced production and gene expression of the pro-inflammatory mediators TNF-α,
IL-1B and IL-6 and increased the parameters on the anti-inflammatory IL-10 cytokine. [51]
EO (5000 ppm) decreased paw edema and ear swelling, inhibited the total mRNA IL-1β
expression in the mouse colon. [52]
Thymus zygis subsp.
zygis
EO thymol type inhibition of 5-lipoxygenase (IC50 = 54 – 73 µL/L).EO linalool type
inhibition of 5-lipoxygenase (IC50 = 299 – 402 µL/L).
[53]
EO reduced production and gene expression of the pro-inflammatory mediators TNF-α,
IL-1B and IL-6 and increased the parameters on the anti-inflammatory IL-10 cytokine. [51]
Myrtaceae
Eucalyptus globulus EO inhibition of 5-lipoxygenase (IC50 = 0.16 mg/mL). [37]
subsp. maidenii EO (0.5µg/mL) inhibition (50%) of lipoxygenase. [45]
EO (200 mg/kg) inhibited by 28.8% the inflammatory phase of wound healing
(Whittle method). [54]
Pinaceae
Pinus pinaster EO (100 mg/kg dose) inhibition (30.3%) of paw edema in the Whittle methodusing carrageenan. [55]
EO: Essential oil. IC50: Half-maximal inhibitory concentration. LDL: Low-density lipoprotein. COX-2: Ciclo-oxigenase-2.
Essential oils are gaining commercial relevance in several countries, such as Portugal or
Angola, as an additional source of income in a context of a more sustainable use of the local
flora. Nevertheless, despite these essential oils being traded, national or internationally,
for specific markets, it is ever more important for their added value to gather scientific
support for their alleged biological properties. Given the traditional and commercial
use of EOs for medicinal and cosmetic purposes and the knowledge of the ability, of
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their monoterpene and sesquiterpene constituents, to act as anti-inflammatories [56,57],
the present work evaluated twenty EOs obtained from eighteen plant species collected in
Portugal and Angola (Table 1) for their effect on the release of CCL2 (MCP-1) and TNF-α
by lipopolysaccharide (LPS)-stimulated THP-1 cells.
2. Material and Methods
2.1. Plant Material
Collective and/or individual samples, from cultivated and wild-growing medicinal
and aromatic plants, were collected from mainland Portugal (Table 3). As a rule, the plant
material was collected during the local producers’ harvesting season. For herbaceous
species, this was usually at the flowering phase, whereas for trees, it was at landscaping
time. If not immediately extracted, the plant material was stored at −20 ◦C until essential
oil (EO) isolation. Dried aerial parts from commercially available products sold in local
herbal shops were also analyzed, as well as the essential oils isolated from oleoresin, in
the case of Pinus pinaster, and from the two species from Angola (Table 3). A total of
twenty essential oils isolated from eighteen species from the Amaranthaceae, Apiaceae,
Asteraceae, Euphorbiaceae, Lamiaceae, Myrtaceae and Pinaceae families were tested. A
voucher specimen of each plant species, collected from the wild state condition, was
deposited in the Herbarium of the Botanical Garden of Lisbon University, Lisbon, Portugal.
For commercial plant material, a reference sample from each plant is retained at the CBV
laboratory and is available upon request.
2.2. Extraction and Chemical Analysis of the Essential Oils
Essential oils were extracted by hydrodistillation for 3 h, using a Clevenger-type appa-
ratus, according to the European Pharmacopoeia [59], and stored at −20 ◦C until analysis.
The EOs were analyzed by gas chromatography (GC) for component quantification and
gas chromatography coupled to mass spectrometry (GC-MS) for component identification.
2.2.1. Gas Chromatography (GC)
Gas chromatographic analyses were performed using a Perkin Elmer Clarus 400 gas
chromatograph equipped with two flame ionization detectors (FIDs), a data handling
system and a vaporizing injector port into which two columns of different polarities were
installed: a DB-1 fused-silica column (polydimethylsiloxane, 30 m × 0.25 mm i.d., film
thickness 0.25 µm; J & W Scientific Inc., Rancho Cordova, CA, USA) and a DB-17HT
fused-silica column ((50% phenyl)-methylpolysiloxane, 30 m × 0.25 mm i.d., film thickness
0.15 µm; J & W Scientific Inc.). The oven temperature was programmed from 45 to 175 ◦C,
at 3 ◦C/min, and subsequently at 15 ◦C/min up to 300 ◦C, and then held isothermal
for 10 min; injector and detector temperatures were 280 ◦C and 300 ◦C, respectively; the
carrier gas, hydrogen, was adjusted to a linear velocity of 30 cm/s. The samples were
injected using a split sampling technique, ratio 1:50. The volume of injection was 0.1 µL
of n-pentane-essential oil solution (1:1). The percentage composition of the volatiles was
computed, by the normalization method from the GC peak areas, and calculated as the
mean values of two injections, from each sample, without using the response factors.
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Table 3. List of the evaluated species, sampling year, plant part used for hydrodistillation, plant source, essential oil yield











Dysphania ambrosioides Da 2013 FF Monsaraz 0.56 iso-Ascaridole 51,ascaridole 16
Apiaceae
Foeniculum vulgare Fv 2013 DV Herbal shop α-Pinene 27, trans-anethole18, Limonene 11
Fv s 2013 Seeds Herbal shop 1.16 Methyl chavicol 79,limonene 12
Asteraceae
Brachylaena huillensis Bh 2013 EO Angola n.a. Copaen-15-ol * 14
Bh * 2013 EO* Angola n.a. Copaen-15-ol * 12
Solidago virgaurea a Sv 2013 FF Pinheiro da Cruz 0.72




Spirostachys africana 2013 EO Angola n.a. Stachenone * 28,Diosphenol (2) * 38
Lamiaceae





Mentha cervina Mc 2013 DV Herbal shop 1.54 Pulegone 76
Origanum majorana a Om 2013 DV Herbal shop 0.98
Terpinen-4-ol 18, carvacrol
17, γ-terpinene 13,
carvacrol methyl ether 13
Satureja montana a Sm 2013 DV Herbal shop 1.48 Carvacrol 77
Thymbra capitata Tc 2013 FV Algarve 0.89 Carvacrol 71
Thymus mastichina Thm 2013 FF Bragança 1.35 1,8-Cineole 69
Thymus pulegioides a Thp 2013 DL Herbal shop 0.49 Thymol 32, ρ-cymene 22
Thymus vulgaris a Thv 2013 DV Herbal shop 1.20 Thymol 45, ρ-cymene 21,
γ-terpinene 16
Thymus zygis subsp.
zygis a Thzz 2013 FF Bragança 0.71




subsp. maidenii Eg 2013 FL MEE 3.20
α-Pinene 15, 1,8-Cineole
46, Limonene 23
Eucalyptus radiata Er 2012 FL MEE 7.20 1,8-Cineole 49
Eucalyptus viminalis Ev 2012 FL MEE 2.50 α-Pinene 10, 1,8-Cineole 69
Pinaceae
Pinus pinaster Pp 2013 Oleoresin Nazaré 29.76 α-Pinene 62, β-pinene 23
# Unless otherwise specified, the collection place was in Portugal. a Detailed composition of EOs reported in Faria et al. [58]. b Commercial-
ized as Lavandula stoechas L. n.a.: Information not available. * Identification based on mass spectra only. DF: Dry, flowering phase aerial
parts. DL: Dry leaves. DV: Dry, vegetative phase aerial parts. EO: Essential oil supplied by the producer, obtained from the wood. EO*:
In-lab re-distilled essential oil supplied by the producer, due to some turbidity of the original sample. FF: Fresh, flowering phase aerial
parts. FL: Fresh leaves from fruiting phase. MEE: Mata Experimental do Escaroupim.
2.2.2. Gas Chromatography-Mass Spectrometry (GC-MS)
The GC-MS unit consisted of a Perkin Elmer Clarus 600 gas chromatograph, equipped
with a DB-1 fused-silica column (30 m × 0.25 mm i.d., film thickness 0.25 µm; J & W
Scientific, Inc.), and interfaced with a Perkin Elmer 600T mass spectrometer (software
version 5.4.2.1617, Perkin Elmer, Shelton, CT, USA). Injector and oven temperatures were
as above; transfer line temperature, 280 ◦C; ion source temperature, 220 ◦C; the carrier gas,
helium, was adjusted to a linear velocity of 30 cm/s; split ratio, 1:40; ionization energy,
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70 eV; scan range, 40–300 u; scan time, 1 s. The identity of the components was assigned by
comparison of their retention indices, relative to n-alkane indices and GC-MS spectra from a
lab-made library, created with reference essential oils, laboratory-synthesized components,
laboratory-isolated compounds and commercially available standards.
2.3. In Vitro Inhibition of TNF-α and CCL2
This assay was performed according to Campana et al. [60]. Briefly, THP-1 cells
(ATCC TIB-202) were cultivated in RPMI 1640 medium supplemented with 0.05 mM 2-
mercaptoethanol, 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 µg/mL
gentamicin at 37◦C in an atmosphere containing 5% CO2. The medium was renewed twice
a week when the cell concentration reached 1.0 × 106 cells/mL. The cells were transferred
to a 96-well microplate at a concentration of 100,000 cells per well and incubated for
18 h with RPMI supplemented with 1% FBS to initiate serum starvation, which was kept
throughout the experiment.
The cells were pre-treated with EOs at three concentrations for 3 h. To determine
each EO working concentration, the toxicity of the EOs on THP-1 cells was accessed
by measuring cell viability using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) method and untreated cells as the reference for viability [61]. EOs were
considered nontoxic for the THP-1 cell line, and adequate for further analysis, when cell
viability was higher than 90%. The EO concentrations ranged from 3 µg/mL to 90 µg/mL
(Dysphania ambrosioides, Eucalyptus globulus, E. radiata, E. viminalis, Foeniculum vulgare,
Lavandula stoechas, Mentha cervina, Origanum majorana, Pinus pinaster, Solidago virgaurea,
Thymus mastichina, Th. pulegioides (Thymus abbreviated to Th., to avoid confusion with T.
from Thymbra), Th. vulgaris), from 3 µg/mL to 30 µg/mL (Brachylaena huillensis, Satureja
montana, Spirostachys africanus, Th. zygis) and from 5 µg/mL to 90 µg/mL (Thymbra capitata)
(Table 4).
Table 4. Inhibition of TNF-α and CCL2 production by lipopolysaccharide (LPS)-activated THP-1 monocytic cells elicited by
the evaluated essential oils (EOs).
Family/Species and Control Concentrations(µg/mL)
TNF-α Inhibition
(% ± S.D., n = 3)
CCL2 Inhibition
(% ± S.D., n = 3)
Control LPS (200 ng) 2428.1 ± 587.8 a 2382.3 ± 1480.8 a
DMSO (0.1%) 96.5 ± 13.9 a 24.1 ± 14.7 a
Amaranthaceae
Dysphania ambrosioides 90 48.6 ± 2.1 *** 15.6 ± 0.7 ***
30 30.9 ± 1.5 * 9.4 ± 0.3 **
10 13.6 ± 1.0 7.5 ± 0.3 *
Apiaceae
Foeniculum vulgare 90 22.3 ± 1.9 *** NI
30 0.5 ± 0.0 NI
10 NI NI
Asteraceae
Brachylaena huillensis 30 NI 18.8 ± 2.3 **
(re-distilled EO) 10 4.4 ± 0.8 9.0 ± 0.5
3 NI 5.4 ± 0.2
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Table 4. Cont.
Family/Species and Control Concentrations(µg/mL)
TNF-α Inhibition
(% ± S.D., n = 3)
CCL2 Inhibition
(% ± S.D., n = 3)
Brachylaena huillensis 30 ND ND
10 ND ND
3 ND ND
Solidago virgaurea 90 ND ND
30 5.0 ± 0.2 ND
10 NI 4.9 ± 0.1 *
3 ND 8.0 ± 0.1 **
Euphorbiaceae




Lavandula luisieri 90 82.9 ± 8.2 *** 82.0 ± 12.4 ***
30 23.2 ± 1.1 *** 54.3 ± 3.0 ***
10 2.5 ± 0.1 22.7 ± 1.0 ***
Mentha cervina 90 NI NI
30 NI NI
10 NI 2.5 ± 0.0
Origanum majonara 90 NI NI
30 NI NI
10 NI 4.8 ± 0.1
Satureja montana 30 ND ND
10 ND ND
3 NI 0.2 ± 0.0
Thymbra capitata 30 ND NI
20 51.1 ± 6.5 *** ND
10 29.5 ± 1.7 *** 0.4 ± 0.0
5 9.1 ± 0.1 * ND
Thymus mastichina 90 ND ND
30 ND ND
10 ND ND
Thymus pulegioides 90 ND ND
30 NI 0.9 ± 0.0
10 NI 8.4 ± 0.5
Thymus vulgaris 90 ND ND
30 ND ND
10 ND ND
Thymus zygis ssp. sygis 30 NI 8.9 ± 1.0
10 NI 2.7 ± 0.2
3 NI 0
Myrtaceae
Eucapyptus globulus subsp. 90 6.5 ± 0.4 1.7 ± 0.0
maidenii 30 4.4 ± 0.3 NI
10 2.4 ± 0.2 NI
Eucalyptus radiata 90 12.0 ± 0.1 * NI
30 NI NI
10 NI NI
Eucalyptus viminalis 90 3.3 ± 0.2 NI
30 0.2 ± 0.0 NI
10 NI 1.4 ± 0.0
Pinaceae
Pinus pinaster (oleoresin) 90 ND ND
30 6.3 ± 0.1 NI
10 6.8 ± 0.3 NI
a Inflammatory mediator production (absolute values in pg/mL). NI: No inhibition. ND: Not determined due to toxicity (cell viabil-
ity ≤ 90%). * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001: Indicates significant inhibition of TNF-α or CCL2 release in comparison to LPS-stimulated
cells (ordinary one-way ANOVA/Newman–Keuls multiple comparison test: GraphPad Prism).
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Lipopolysaccharide (LPS) from Escherichia coli 0111:B4 (Sigma), added at 200 ng/mL,
was employed as the inflammatory stimulus. The plate was incubated at 37◦C overnight.
After this period, the plate was centrifuged (1800 g, 5 min, 16◦C), the supernatant collected
and TNF-α release measured using the cytokine-specific sandwich quantitative ELISA
according to the manufacturer’s instructions (TNF-α duo set, DY210, R&D Systems, Min-
neapolis, MN, USA). CCL2 release was measured using the cytokine-specific sandwich
quantitative ELISA according to the manufacturer’s instructions (Human CCL2/MCP-
1 duo set, DY279, R&D Systems, Minneapolis, MN, USA). Dexamethasone was em-
ployed as positive control (0.3 µM). The statistical significance of differences was cal-
culated employing the software GraphPad Prism, version 5.0 (GraphPad Software Inc.,
San Diego, CA, USA), using ordinary one-way ANOVA/Newman–Keuls multiple compar-
ison test. All the experiments were performed in triplicate.
3. Results and Discussion
3.1. Chemical Composition of the Essential Oils
All essential oils were fully chemically characterized. Table 3 reports only their main
constituents (≥10%), since, in some cases, duly marked in Table 3, the detailed composition
was previously reported, or their composition was overall very similar to data from prior
studies. In the case of EOs from Angola, the complexity of the EOs still requires additional
characterization for the full identification of some minor components.
Although commercialized as Lavandula stoechas L., the presence of necrodane deriva-
tives, such as 5-methylene-2,3,4,4-tetramethylcyclopent-2-enone (18%) in the analyzed
essential oil, undoubtedly indicated that the butterfly lavender tested was L. luisieri and not
L. stoechas (Table 3). The chemical composition of L. stoechas essential oil is characterized
by large variations in fenchone, camphor and 1,8-cineole amounts, whereas necrodane
derivatives are characteristic of L. luisieri [23,24,62]. Even though some variations in their
contents were observed, the remaining essential oil compositions were in accordance with
previous studies carried out with Foeniculum vulgare [15,63], Mentha cervina ([25] and refer-
ences therein), Origanum majorana [64], Satureja montana [58,65], Thymbra capitata, Thymus
mastichina, Th. pulegioides, Th. vulgaris and Th. zygis subsp. zygis [28,64–66], Eucalyptus
species [67,68] and Pinus pinaster [33,69].
Although a few studies evaluated the EO composition from Brachylaena huillensis
aerial parts, only three studies reported the essential oil composition from the wood or saw
powder of this species [16,17,70]. Although no detailed composition has been reported,
α-amorphene was the dominant constituent in the studies of Klein and Schmidt [70] and
of Maitai et al. [16] (17% and 15%, respectively), whereas β-caryophyllene (19%) was the
major constituent described by Oliva et al. [17]. In the present study, α-amorphene was
the second main component, together with gleenol (both 6%), whereas β-caryophyllene
was found only in trace amounts. Baarschers et al. [20] reported the isolation of diterpenes
from Spirostachys africana wood, but no previous studies addressed the EO composition
from the wood.
3.2. In Vitro Inhibition of TNF-α Release by LPS-Stimulated THP-1 Cells
The potential anti-inflammatory activity of essential oils (EOs) was investigated by
measuring TNF-α release by lipopolysaccharide (LPS)-stimulated THP-1 cells by employ-
ing an immunoassay. The toxicity of the EOs on THP-1 cells was accessed to determine
the adequate EO working concentrations. When the cell viability of THP-1 cells was
higher than 90%, samples were considered non-cytotoxic and adequate for further analysis.
According to the availability of EO, at least three concentrations were checked for each
essential oil (Table 4). Data in Table 4 also include information on EOs which were not
assessed further due to being toxic (ND) to differentiate them from those that showed no
inhibition (NI).
The EOs of T. capitata, L. luisieri, F. vulgare and D. ambrosioides significantly reduced
TNF-α release by LPS-stimulated THP-1 cells, in comparison to the control cells. From
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these four EOs, those of T. capitata and L. luisieri were the most effective. T. capitata EO
showed an inhibition percentage of TNF-α release of 51 ± 7% at 20 µg/mL, whereas that
of L. luisieri EO was 23 ± 1% at 30 µg/mL and 83 ± 8% at 90 µg/mL (Table 4). These
inhibition percentages were higher than those of D. ambrosioides EO (49 ± 2% at 90 µg/mL),
or F. vulgare EO (22 ± 2% at 90 µg/mL) (Table 4).
The potential anti-inflammatory activity of L. luisieri, F. vulgare and T. capitata EOs
has been previously reported using different in vitro and in vivo models (Table 2), but
as far as we know, the anti-inflammatory potential of D. ambrosioides EO has not been
addressed to date. Recently, the anti-inflammatory activity of alcoholic or hydroalcoholic
extracts of D. ambrosioides was reported as showing the ability to reduce interleukin 6 (IL-6),
myeloperoxidase (MPO), nitric oxide (NO) and adenosine-deaminase (ADA) activity and
TNF-α and, therefore, they are potentially useful in wound healing and in the treatment of
arthritic processes [13,71]. The oxygen-containing monoterpene ascaridole was identified
as a constituent of D. ambrosioides ethanolic extract by Grassi et al. [13], a compound also
identified in the essential oils evaluated in the present work (Table 3).
Despite carvacrol being the main compound of T. capitata EO (Table 3), this phenol-like
oxygen-containing monoterpene may not be the only compound accountable for T. capitata
EO activity. Indeed, other carvacrol-rich EOs, such as those of S. montana and Th. zygis
(Table 3), were not able to reduce TNF-α release. The presence of antagonists in these EOs
can also not be ignored. Moreover, it is relevant to highlight the important role of the minor
compounds and/or some of the compounds’ enantiomeric ratio in the overall activity of
EOs. Often overlooked, these factors can contribute to synergistic or antagonistic actions
determining differences in the EOs’ activities [56,72]. These results make it difficult to
predict the effect of different species’ essential oils that share the same major component
for TNF-α release.
Th. pulegioides and, particularly, Th. vulgaris EOs, with thymol, an isomer of carvacrol
as the main component (Table 3), were toxic for THP-1 cells, even at lower concentrations
(Table 4). Th. vulgaris EO has been reported to show anti-inflammatory activity, including
the capacity of reducing TNF-α release, this activity being related solely to the higher
carvacrol content [37,49,50,52]. On the other hand, Th. zygis and Th. vulgaris EOs, which
have thymol as the main constituent, have been reported to decrease TNF-α secretion
by human macrophages derived from THP-1 monocytes and activated by oxidized (ox)-
LDLs [51]. Dexamethasone at 0.3 µM had > 90% inhibition.
3.3. In Vitro Inhibition of CCL2 Release by LPS-Stimulated THP-1 Cells
Inflammatory changes in arterial lesions are characterized by the recruitment and
activation of monocytes/macrophages, which are regulated by CCL2. This chemoattractant
cytokine has been shown to play a vital role in the initiation and progression of arterioscle-
rotic lesions in experimental animals [73]. The effect of the essential oils on CCL2 release
by LPS-stimulated THP-1 cells was also evaluated.
Of the four essential oils with the ability to inhibit CCL2 release, only L. luisieri EO had
remarkable activity, with inhibition percentages of 23 ± 1%, 54 ± 3% and 82 ± 12% at 10,
30 and 90 µg/mL, respectively (Table 4). The major compound of L. luisieri EO, 5-methylene-
2,3,4,4-tetramethylcyclopent-2-enone, a necrodane derivative, may have contributed to this
activity, along with 1,8-cineole. Nevertheless, the absence of the activity of other EOs in
which 1,8-cineole was also present, even in a much higher percentage, such as Th. mastichina
or Eucalyptus EOs (Table 3), may suggest that 5-methylene-2,3,4,4-tetramethylcyclopent-2-
enone plays an important role in the inhibition of both TNF-α and CCL2 release (Table 4).
The inhibitory activities elicited by D. ambrosioides, S. virgaurea or B. huillensis EOs were
much lower (Table 4). Dexamethasone at 0.3 µM had > 90% inhibition.
Reports regarding the action of essential oils and/or their main components on the
production of CCL2 are scarce. Limonene isolated from Citrus junos EO was able to
inhibit CCL2 production on diesel exhaust particle (DEP)-stimulated human eosinophilic
leukemia HL-60 clone 15 cells [74]. Artemisia argyi EO, mainly constituted by 1,8-cineole
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(33%), camphor (17%), (-)-borneol (13%) and α-thujone (13%), reduced TNF-α, IL-6, IFN-β
and CCL2 in LPS-induced RAW264.7 macrophages [75]. Xiao Qing Long Tang essential
oil was able to suppress CCL2, IL-1β, IL-6, IL-10 and TNF-α expression and production
by LPS-stimulated RAW264.7 cells [76]. In addition, Park et al. [77] also reported that
(-)-linalool was able to inhibit microglial migration induced by CCL2, a chemokine released
by oxygen-glucose deprivation/reoxygenation (OGD/R) in cortical cells from 17-day-old
embryos of Sprague-Dawley rats.
Along with L. luisieri EO, the ascaridole- and iso-ascaridole-rich D. ambrosioides EO
was also able to reduce CCL2 release by LPS-stimulated THP-1 cells, as observed for
TNF-α, although in a weaker manner (Table 4). The absence of these compounds in the
remaining non-active EOs may suggest that these volatile compounds have an important
role in the suppression of some inflammatory processes in which TNF-α and CCL2 are
involved. Despite the traditional application of D. ambrosioides as a vermifuge and against
vomiting [14], this is the first report on the effect of its essential oil on the release of the
pro-inflammatory cytokine TNF-α and the chemokine CCL2. For this reason, this EO
and its main component ascaridole, and/or its isomers, should be further investigated to
explore their anti-inflammatory activity.
4. Conclusions
Inflammatory disorders are usually treated with steroidal anti-inflammatory drugs
(SAIDs) or non-SAIDs (NSAIDs). Nevertheless, because these drugs present multiple
negative side effects, it is important to assess and validate the use of other potential anti-
inflammatory agents, namely, essential oils. Moreover, some of these essential oils are
by-products from landscaping activities or other industries, thus constituting an added
value to countries’ local flora.
This study suggests that T. capitata and L. luisieri EOs, mainly constituted by carvacrol
and 5-methylene-2,3,4,4-tetramethylcyclopent-2-enone and 1,8-cineole, respectively, were
the most effective to inhibit TNF-α release by LPS-stimulated THP-1 cells, whereas only
L. luisieri EO had the ability to inhibit CCL2 release by LPS-stimulated THP-1 cells.
EOs’ chemical complexity and variability (existence of chemotypes and/or the enan-
tiomeric ratio of some components), their hydrophobicity and, sometimes, their scarcity,
have been considered some of the limitations to their use in diverse formulations. Never-
theless, EOs are Generally Regarded as Safe (GRAS), and the knowledge on their biological
properties should be further explored, in solo formulations and in combination therapies,
as potential anti-inflammatory agents. This approach would contribute to the goal of
decreasing the use of SAIDs and, therefore, preventing or diminishing these drugs’ adverse
side effects.
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CCL2 Chemokine (C-C motif) ligand 2
COX-2 Cyclooxygenase-2
DF Dry, flowering phase aerial parts
DL Dry leaves
DV Dry, vegetative phase aerial parts
EOs Essential oils
FBS Fetal bovine serum
FF Fresh, flowering phase aerial parts
FL Fresh leaves from fruiting phase
IC50 Half-maximal inhibitory concentration
LDL Low-density lipoprotein
LPS Lipopolysaccharide
MCP-1 Monocyte chemoattractant protein-1
MEE Mata Experimental do Escaroupim
MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide
THP-1 Human acute monocytic leukemia cell line
TNF-α Tumor necrosis factor-α
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